SBI, ITC and Sun Pharma among stocks to watch on Tuesday
Several companies are expected to see movement following quarterly results and corporate announcements, according to Mint.
Several stocks, including State Bank of India (SBI), ITC, and Sun Pharmaceuticals, are expected to remain in focus during Tuesday's trading session, according to Mint. The Indian stock market is likely to open positively following a strong previous session where the Sensex and Nifty 50 both recorded significant gains.
State Bank of India, National Stock Exchange of India, Bajaj Finserv, Lupin, Multi Commodity Exchange of India, and Emcure Pharmaceuticals are scheduled to release their Q2 2026 results today. In recent earnings, ITC reported an 18.5 per cent year-on-year decline in consolidated net profit to ₹4,229 crore for Q2FY27, citing weaker cigarette business earnings.
Marico posted a 31 per cent year-on-year jump in consolidated net profit to ₹550 crore for the September quarter, while its revenue rose 12 per cent to ₹3,897 crore. Granules India also saw a 39.2 per cent year-on-year increase in consolidated net profit to ₹182 crore for Q2FY27.
Other corporate developments include National Aluminium Company (NALCO) approving an interim dividend of ₹4.50 per share for FY27. Meanwhile, employees of IDBI Bank have started a two-day nationwide strike on November 2 to protest the potential transfer of the government's majority interest in the lender to Canada's Fairfax Financial Holdings.
Sun Pharmaceutical Industries clarified that media reports regarding a production suspension for an eye-care drug at one facility related to August 2026 and that no new events occurred on October 30, 2026.